How Has The Head And Neck Cancer Diagnostics Market Size Evolved Historically?
The head and neck cancer diagnostics market has seen considerable growth due to a variety of factors.
•The market size for diagnostics related to head and neck cancer has seen swift expansion in the last few years. Expected to increase from a worth of $1.74 billion in 2024 to $2.05 billion in 2025, it will develop at a compound annual growth rate (CAGR) of 17.4%.
Factors contributing to the growth during the historical period include tobacco and alcohol use, a rising aged population, awareness drives, advancements in biopsy techniques, and the growth of the healthcare infrastructure.
What Will Be The Head And Neck Cancer Diagnostics Market Size In The Future?
The head and neck cancer diagnostics market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, a quick expansion is anticipated in the market for head and neck cancer diagnostics. The market size is projected to reach $3.87 billion in 2029, growing at a compound annual growth rate (CAGR) of 17.3%.
Factors contributing to the predicted growth over this period encompass the existence of genomic biomarkers, the increasing occurrence of hpv-related cancers, the incorporation of artificial intelligence (AI), immunotherapy, targeted therapies, as well as alterations in healthcare policies and reimbursements. Key trends for the coming period involve the dominance of liquid biopsy, the implementation of multi-modality diagnostics and point-of-care diagnostics, international alliances and partnerships, and the integration of digital pathology.
What Are The Primary Growth Drivers In The Head And Neck Cancer Diagnostics Market?
The escalating number of head and neck cancer occurrences is projected to boost the expansion of the head and neck cancer diagnostics market in the future. Head and neck cancer refer to a collection of malignancies found in the tissues and organs of the head and neck region, such as the mouth, larynx, pharynx, salivary glands, sinuses, and nasal cavity. Diagnostics for head and neck cancer aids in the early detection of the disease in patients through various tests like a barium swallow test and an incisional biopsy. For example, as reported by the American Society of Clinical Oncology, a professional organization for physicians and oncology professionals stationed in the US, in February 2023, 4% of all cancer types in the US were head and neck cancer. This type of cancer is anticipated to impact 66,920 individuals in the USA in 2023, comprising 49,190 men and 17,730 women. Globally, in 2020, head and neck cancer has affected 562,328 people. Additionally, as per Australia's head and neck cancer statistics, 5,189 new cases surfaced in 2022. Hence, the escalating incidence of head and neck cancer is fueling the growth of the head and neck cancer diagnostics market.
What Is The Segmentation Of The Global Head And Neck Cancer Diagnostics Market?
The head and neck cancer diagnostics market covered in this report is segmented –
1) By Diagnostic Method: Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods
2) By Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
3) By End-User: Hospitals, Diagnostic Centers, Other End Users
Subsegments:
1) By Diagnostic Imaging Equipment: Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, X-rays
2) By Endoscopy Screening Equipment: Rigid Endoscopes, Flexible Endoscopes, Video Endoscopy Systems
3) By Biopsy Screening Tests: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy
4) By Dental Diagnostic Methods: Intraoral Cameras, Dental X-rays, Oral Cancer Screening Devices
5) By Other Diagnostic Methods: Molecular Diagnostics, Blood Tests, Genetic Testing
Pre-Book The Head And Neck Cancer Diagnostics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Head And Neck Cancer Diagnostics Market Landscape?
Product innovation is becoming an increasingly noticeable trend in the head and neck cancer diagnostic market as key market players are focusing their efforts on the development of innovative goods to solidify their market presence. For example, Alkem Laboratories Ltd., a healthcare organization based in India, introduced Cetuxa in May 2023. This is intended to be the world's first biosimilar for the treatment of head and neck cancer. The Cetuxa is a biosimilar of cetuximab, a monoclonal antibody that restricts the receptor-dependent transduction pathway and possesses anti-tumor attributes. The location where cetuximab binds can be found in the extracellular domain of the epidermal growth factor receptor (EGFR). Cetuximab is often used in conjunction with chemotherapy or radiation therapy during medical practice. It can be used to treat squamous cell carcinoma of the head and neck when it is locally advanced, recurrent, or metastatic.
Who Are the Key Players in the Head And Neck Cancer Diagnostics Market?
Major companies operating in the head and neck cancer diagnostics market include:
• F. Hoffmann-La Roche Ltd.
• Bristol Myers Squibb Co.
• Abbott Laboratories
• Siemens Healthineers AG
• BioNTech AG
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Laboratory Corporation of America
• Agilent Technologies Inc.
• Hologic Inc.
• Illumina Inc.
• Shimadzu Corporation
• Sysmex Corp.
• Varian Medical Systems Inc.
• QIAGEN N.V.
• Exact Sciences Corp.
• Bio-Techne Corp.
• Carestream Health Inc.
• Myriad Genetics Inc.
• Cepheid Inc.
• Invitae Corporation
• Accuray Inc.
• Canon Medical Systems Corporation
• NanoString Technologies Inc
• Asuragen Inc.
• Caris Life Sciences Inc.
• HTG Molecular Diagnostics Inc.
• Oncgnostics GmbH
• Perseus Proteomics Inc.
• VolitionRx Ltd.
What are the Regional Insights into the Head And Neck Cancer Diagnostics Market?
North America was the largest region in the head and neck cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
